Login to Your Account

Trial Design Trips Up Tivozanib, AVEO Pharma Stock Swoons

By Catherine Shaffer
Staff Writer

Wednesday, February 13, 2013
Stock in AVEO Pharmaceuticals Inc. softened following a clinical trial update released in conjunction with the company's full year 2012 earnings.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription